Reporter
Park named director of Hematology and Oncology at VICC
Oct. 21, 2020—After serving as interim director since Jan. 1, Ben Ho Park, MD, PhD, Donna S. Hall Professor of Breast Cancer Research at Vanderbilt University Medical Center, has been named director of the Division of Hematology and Oncology.
‘Black in Cancer’ promotes diversity in research
Oct. 21, 2020—Black In Cancer, an initiative cofounded by Henry Henderson III, PhD, a postdoctoral researcher at Vanderbilt-Ingram Cancer Center, is making an impact just two months after its inception.
Vanderbilt Health to be founding member of Pro Football Hall of Fame’s Health Network
Oct. 20, 2020—Vanderbilt Health is one of 12 of the nation’s premier providers of medical care that will begin offering services to any former National Football League player or team employee, and their families, under the banner of Hall of Fame Health.
Ascension St. Thomas, Tristar Health, Meharry Medical College/Nashville General Hospital, Vanderbilt Health issue joint statement on COVID-19
Oct. 20, 2020—The number of active COVID-19 cases in Tennessee is rising. In the 13 counties that comprise the Nashville Metropolitan Area, new cases have increased 50% over the last 2 weeks. We strongly urge everyone in Middle Tennessee, and all Tennesseans, to remain vigilant in their efforts to limit the spread of the virus by wearing masks, washing hands and staying socially distant — including not participating in large gatherings.
Three from Vanderbilt elected to the National Academy of Medicine
Oct. 20, 2020—Three members of the Vanderbilt University School of Medicine faculty have been elected this year to the National Academy of Medicine (NAM), the organization announced Monday, Oct. 19.
Preserving gut mucus architecture
Oct. 20, 2020—A new method that keeps microbes and gut cells together will be useful for studies of complex host-microbe interactions and for analysis of clinical specimens.
Depression and the brain-age gap
Oct. 19, 2020—Older depressed adults show accelerated brain aging, according to a new study from Vanderbilt researchers, who suggest that the effects of depression may speed the decline in cognitive functions in older individuals.
Clinical trial to test HIV drugs to treat COVID-19
Oct. 16, 2020—Vanderbilt University Medical Center, in collaboration with the University of Colorado and Beth Israel Deaconess Medical Center in Boston, is leading one of the first “telemedicine” clinical trials to test a potential treatment for COVID-19.
Possible COVID-19 “decoy”
Oct. 15, 2020—It might be possible to use vesicles carrying the receptor for SARS-CoV-2, the virus that causes COVID-19, to bind the virus and prevent infection.
Living liver donor program performs first transplant
Oct. 15, 2020—The Vanderbilt Transplant Center's newly launched living liver donor program allows relatives to donate part of their liver to their loved one, something only possible at select centers in the country.
Noninvasive treatment for refractory OCD, major depression shows promise for lifelong benefits
Oct. 15, 2020—Four months ago, a multidisciplinary care team at Vanderbilt University Medical Center treated a patient with lifelong major depressive disorder (MDD) and obsessive compulsive disorder (OCD) — conditions that left her debilitated with intrusive thoughts, constant fear, suicidal intent and anorexia.
Study explores nicotine patch to treat late-life depression
Oct. 15, 2020—Backed by nearly $5 million in funding, researchers from Vanderbilt University Medical Center are testing to see whether transdermal nicotine patches can improve mood, forgetfulness and attentiveness in adults over 60 with a diagnosis of depression.
